Glycosaminoglycan-antagonising mcp-i mutants and methods of...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/52 (2006.01) A61K 38/19 (2006.01) C12N 15/12 (2006.01)

Patent

CA 2750983

Novel mutants of human monocyte chemoattractant protein 1 (MCP-1) with increased glycosamino-glycan (GAG) binding affinity and knocked-out or reduced GPCR activity compared to wild type MCP-1, and their use for therapeutic treatment of inflam-matory diseases.

La présente invention porte sur de nouveaux mutants de la protéine chimiotactique pour les monocytes humaine 1 (MCP-1) dotée d'une affinité de liaison accrue pour les glycosaminoglycanes (GAG) et d'une activité GPCR neutralisée ou réduite par comparaison avec la MCP-1 de type sauvage, et sur leur utilisation pour le traitement thérapeutique de maladies inflammatoires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glycosaminoglycan-antagonising mcp-i mutants and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycosaminoglycan-antagonising mcp-i mutants and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycosaminoglycan-antagonising mcp-i mutants and methods of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1815434

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.